PREcision MEDicine In Achalasia (PREMEDIA) (PREMEDIA)
PREcision MEDicine In Achalasia - 非痙攣性アカラシアに対する短縮型テーラードPOEM対標準POEMの多施設共同ランダム化非劣性臨床試験および痙攣性食道運動障害に対する延長型テーラードPOEMの多施設共同前向きコホート研究
The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question[s] it aims to answer [is/are]:
- Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms?
- Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
調査の概要
状態
詳細な説明
The investigators will perform a randomized controlled trial to compare two different approaches to Peroral Endoscopic Myotomy (POEM) for treating achalasia (Types I and II) and esophagogastric junction outflow obstruction (EGJOO). The most widely used treatment for achalasia is POEM but the current approach involves a 9 cm (3.5 inch) myotomy (cutting of the muscle) to open up the tight lower esophageal sphincter to promote food delivery from the esophagus to the stomach. This approach is very effective, with success rates of approximately 90% over the short term. However, the investigators believe that POEM does not require a full 9 cm myotomy and that the investigators can cut much less muscle (approximately 4cm/1.25inches) to achieve similar improvement in symptoms but with less long-term complications. Cutting less muscle may result in less acid reflux, which is the Achilles heel of any successful treatment for achalasia. A shorter muscle cut may also result in less of a complication known as blown-out myotomy, which causes failure of the esophagus to empty its contents and is a major cause of long-term symptom relapse. The investigators have designed this study to determine whether the shorter myotomy (4 cm) is equivalent to the longer myotomy (9 cm) in terms if symptom improvement, but with the possibility of less acid reflux and blown-out myotomy.
Given these questions, the investigators will enroll 370 patients in a randomized trial where patients will receive either the short tailored (4cm/1.25 inches) or the standard myotomy (9cm/3.5 inches). All patients will undergo intraoperative assessment of success of the myotomy by using a special tool called the functional lumen imaging probe (FLIP). The FLIP will measure the opening dimensions of the lower esophageal sphincter and ensure that the myotomy is adequately performed so that the lower esophageal sphincter can open to a level that will improve esophageal emptying/swallowing. The investigators will follow patients for 2 years in a manner similar to how the investigators would follow patients after achalasia treatment in standard clinical practice. The investigators will assess whether symptoms are similar and whether or not there are differences in acid reflux and esophageal emptying. Patients will undergo follow up testing with questionnaires at intervals of 3-6 months over two years and they will have reflux testing (measure acid exposure using a capsule placed during endoscopy) between 6-12 months and a barium esophagram (X ray while drinking barium) at 2 years. The most important aim is to prove that the symptoms and outcomes success/failure) between the two approaches are similar (short myotomy is non-inferior) and the Eckardt score will be the primary questionnaire score for this study. The investigators believe that this study will help define the optimal approach to POEM in achalasia and also help us prevent complications in the future.
Additionally, the investigators will also ask participants to provide a sample of the muscle tissue that is typically cut during the POEM. This tissue will help us develop a tissue bank to help other researchers looking into the causes of why achalasia and these other esophageal diseases occur. The participants can opt out of this part and still continue in the randomized controlled trial.
研究の種類
入学 (推定)
段階
- フェーズ 3
連絡先と場所
研究連絡先
- 名前:Elizabeth Yan, BS
- 電話番号:312-908-1723
- メール:premedia.dcc@northwestern.edu
研究連絡先のバックアップ
- 名前:Yasmin Pina, BS
- 電話番号:312-503-6459
- メール:premedia.dcc@northwestern.edu
研究場所
-
-
Arizona
-
Scottsdale、Arizona、アメリカ、85259
- まだ募集していません
- Mayo Clinic Arizona
-
-
California
-
La Jolla、California、アメリカ、92037
- 募集
- University of California San Diego
-
主任研究者:
- Rena Yadlapati, MD
-
コンタクト:
- Alexander Gonsalves, Lead Study Coordinator
- 電話番号:858-246-5236
- メール:PREMEDIA@health.ucsd.edu
-
-
Colorado
-
Denver、Colorado、アメリカ、80217
- まだ募集していません
- University of Colorado Denver
-
-
Florida
-
Gainesville、Florida、アメリカ、32611
- 募集
- University of Florida
-
主任研究者:
- Peter Draganov, MD
-
コンタクト:
- April Goddard, Lead Study Coordinator, PA-C
- 電話番号:352-273-9483
- メール:DOM-GIResereachTeam@ad.ufl.edu
-
Orlando、Florida、アメリカ、32803
- まだ募集していません
- Adventist Health System/Sunbelt, Inc
-
-
Georgia
-
Atlanta、Georgia、アメリカ、30322
- 募集
- Emory University
-
主任研究者:
- Anand Jain, MD
-
コンタクト:
- Halley Fowler, Lead Study Coordinator
- 電話番号:404-778-3184
- メール:halley.fowler@emory.edu
-
-
Illinois
-
Chicago、Illinois、アメリカ、60611
- 募集
- Northwestern University
-
主任研究者:
- John Pandolfino, MD
-
コンタクト:
- Eric Pfannkuche, Lead Study Coordinator
- 電話番号:312-926-4525
- メール:PREMEDIA@northwestern.edu
-
-
Maryland
-
Baltimore、Maryland、アメリカ、21218
- まだ募集していません
- Johns Hopkins University
-
-
Massachusetts
-
Boston、Massachusetts、アメリカ、02114
- 募集
- Massachusetts General Hospital
-
コンタクト:
- Madison Paylor, Lead Study Coordinator
- 電話番号:617-726-0196
- メール:premedia@mgb.org
-
主任研究者:
- Kyle Staller, MD
-
-
Missouri
-
St Louis、Missouri、アメリカ、63110
- 募集
- Washington University
-
コンタクト:
- Darren Nix, Lead Study Coordinator
- 電話番号:314-273-1432
- メール:Premediasurgerytrial@wustl.edu
-
主任研究者:
- Chandra Gyawali, MD
-
-
New York
-
New York、New York、アメリカ、10065
- まだ募集していません
- Weill Cornell Medical College
-
-
North Carolina
-
Charlotte、North Carolina、アメリカ、28204
- 募集
- Atrium Health/Wake Forest
-
主任研究者:
- Badih Elmunzer, MD
-
コンタクト:
- Greg Scarola, Lead Study Coordinator
- 電話番号:(704) 355-2000
- メール:PREMEDIA@advocatehealth.org
-
-
Ohio
-
Cleveland、Ohio、アメリカ、44109
- 募集
- MetroHealth Medical Center
-
主任研究者:
- Ronnie Fass, MD
-
コンタクト:
- Stephanie Baker, Lead Study Coordinator
- 電話番号:216-778-5736
- メール:premedia@metrohealth.org
-
Cleveland、Ohio、アメリカ、44106
- まだ募集していません
- Case Western Reserve University
-
-
Tennessee
-
Nashville、Tennessee、アメリカ、37232
- 募集
- Vanderbilt University Medical Center
-
主任研究者:
- Dhyanesh Patel, MD
-
コンタクト:
- Larry Raber, Lead Study Coordinator
- 電話番号:615-322-4643
- メール:larry.w.raber@vumc.org
-
-
Texas
-
Dallas、Texas、アメリカ、75246
- 募集
- Baylor Scott & White Health
-
コンタクト:
- Neomy Flores, Lead Study Coordinator
- 電話番号:214-820-9704
- メール:premedia@bswhealth.org
-
主任研究者:
- Vani Albertson Konda, MD
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria
- Age ≥ 18
- Type I achalasia or type II achalasia or cEGJOO
- Eckardt score > 3
Exclusion Criteria
The following exclusion criteria are for the RCT, but 1-13 below also pertain to the observational study:
- Prior POEM
- Prior surgical treatment for achalasia
- Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
- Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
- Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
- Known secondary achalasia related to malignancy (pseudoachalasia)
- Known eosinophilic esophagitis
- Diverticulum (> 2 cm) in distal esophagus
- Megaesophagus
- Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
- Pregnancy
- Standard contraindications to general anesthesia
- Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
- Unwillingness or inability to consent for the study
- Anticipated inability to follow protocol
- Weekly (or more frequent) opioid medication use in the last 2 years
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:4倍
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:標準的筋切開術
|
Myotomy during POEM of 8-10 cm in length, extending 2-3 cm into the gastric cardia; intention to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
|
実験的:テーラード短筋切開術
|
Myotomy during POEM of 4-5 cm in length, extending 1-2 cm into the gastric cardia; intend to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Clinical Response-Overall
時間枠:From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Sex
時間枠:From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Race
時間枠:From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
|
Clinical Response-by Ethnicity
時間枠:From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。